Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells
- PMID: 1630824
Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells
Abstract
Expression of the normal p53 gene promotes cell differentiation, maturation and apoptosis. The mutant p53 gene, which does not function normally, is frequently expressed at elevated levels in tumor cells [for review see Lane, D.P. & Benchimol, S. (1990). Genes Dev., 4, 1-8]. We have analysed the expression of and mutational change in the p53 gene in the peripheral blood cells of 49 primary acute myeloid leukemia (AML) patients. The p53 protein levels were elevated in 37 patients (75%) when measured by immunoprecipitation with antibodies PAb1801 and PAb421, which recognize both normal and mutant forms of the protein. The p53 protein from 32 of these 37 patients was immunoprecipitated by PAb240, which recognizes a conformation of p53 protein associated with point mutations. However, point mutations were detected by single-stranded conformation polymorphism (SSCP) assay and direct sequencing in only three patients at codons 178, 245, 273 and 290. Growth stimulation of normal lymphocytes also generated p53 which was immunoprecipitable by PAb240. Thus, alteration of p53 conformation, rather than acquisition of point mutations, could be the mechanism underlying the increased proliferation of myeloid cells in most AML patients.
Similar articles
-
p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.Mod Pathol. 1999 Jan;12(1):54-60. Mod Pathol. 1999. PMID: 9950163
-
Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.Hematology. 2002 Feb;7(1):13-9. doi: 10.1080/10245330290020090. Hematology. 2002. PMID: 12171773
-
Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.Leukemia. 1994 Sep;8(9):1589-91. Leukemia. 1994. PMID: 8090036
-
p53 alterations in myeloid leukemia.Acta Haematol. 2004;111(1-2):100-6. doi: 10.1159/000074489. Acta Haematol. 2004. PMID: 14646348 Review.
-
Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition.Exp Hematol. 2016 May;44(5):315-21. doi: 10.1016/j.exphem.2016.02.007. Epub 2016 Feb 26. Exp Hematol. 2016. PMID: 26923266 Free PMC article. Review.
Cited by
-
Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis.Am J Pathol. 1999 Sep;155(3):717-21. doi: 10.1016/S0002-9440(10)65170-X. Am J Pathol. 1999. PMID: 10487829 Free PMC article.
-
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.Mol Cell Biol. 2001 Mar;21(5):1874-87. doi: 10.1128/MCB.21.5.1874-1887.2001. Mol Cell Biol. 2001. PMID: 11238924 Free PMC article.
-
Translational regulation of human p53 gene expression.EMBO J. 1996 Aug 15;15(16):4392-401. EMBO J. 1996. PMID: 8861966 Free PMC article.
-
Understanding p53 functions through p53 antibodies.J Mol Cell Biol. 2019 Apr 1;11(4):317-329. doi: 10.1093/jmcb/mjz010. J Mol Cell Biol. 2019. PMID: 30907951 Free PMC article. Review.
-
Chaperones in cell cycle regulation and mitogenic signal transduction: a review.Cell Prolif. 2000 Dec;33(6):341-65. doi: 10.1046/j.1365-2184.2000.00189.x. Cell Prolif. 2000. PMID: 11101008 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous